Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.24.2.u1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Nov. 03, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Jun. 27, 2024
Subsidiary, Sale of Stock [Line Items]                
Cash equivalents   $ 0   $ 0   $ 0    
[custom:TrustAccount-0]   147,275,981   147,275,981        
[custom:RedemptionOfAggregateShares-0]               7,996,024
Cash held in Trust Account for redemptions   $ 89,302,174   $ 89,302,174      
Cash in the Trust Account           $ 142,069,535    
Temporary Equity, Shares Outstanding   5,181,909   5,181,909   13,177,933    
Dissolution expenses       $ 100,000        
Remeasurement of carrying value to redemption value       5,168,504   $ 9,974,792    
Payment to redeeming shareholders $ 72,546,420     72,546,420   72,546,420    
Ordinary shares tendered for redemption       89,302,174   89,302,174    
Offering costs as a reduction of temporary equity       29,576,119        
Gain on waiver of deferred underwriting fees             $ 342,975  
Waiver of deferred underwriting fee payable             $ 6,655,361  
Unrecognized tax benefits   $ 0   0   $ 0    
Cash FDIC insured amount   250,000   250,000        
Share-Based Payment Arrangement, Expense   0            
Class ordinary shares           22,334    
Founder Shares [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-based compensation   $ 0 $ 656,827 $ 0 $ 1,306,437      
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant   659,844   659,844        
Public And Private Warrants [Member]                
Subsidiary, Sale of Stock [Line Items]                
Offering costs       $ 2,429,624        
IPO [Member]                
Subsidiary, Sale of Stock [Line Items]                
Class A ordinary shares sold       19,995,246        
Offering costs   $ 32,005,743   32,005,743        
Underwriting discount amount   3,999,049   3,999,049        
Deferred underwriting fees   6,998,336   6,998,336        
Investor offering costs   18,958,165   18,958,165        
Other offering costs   $ 2,050,193   2,050,193        
Purchase of aggregate shares       $ 18,996,197